These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 16457645)

  • 21. Glioma stem cell research for the development of immunotherapy.
    Xu Q; Yuan X; Yu JS
    Adv Exp Med Biol; 2012; 746():216-25. PubMed ID: 22639171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.
    Alemany R; Gomez-Manzano C; Balagué C; Yung WK; Curiel DT; Kyritsis AP; Fueyo J
    Exp Cell Res; 1999 Oct; 252(1):1-12. PubMed ID: 10502394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locoregional therapies for glioma.
    Mamelak AN
    Oncology (Williston Park); 2005 Dec; 19(14):1803-10; discussion 1810, 1816-7, 1821-2. PubMed ID: 16506634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and future strategies for the treatment of malignant brain tumors.
    Castro MG; Cowen R; Williamson IK; David A; Jimenez-Dalmaroni MJ; Yuan X; Bigliari A; Williams JC; Hu J; Lowenstein PR
    Pharmacol Ther; 2003 Apr; 98(1):71-108. PubMed ID: 12667889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical development of experimental virus-mediated gene therapy for malignant glioma.
    Rainov NG; Heidecke V
    Anticancer Agents Med Chem; 2011 Oct; 11(8):739-47. PubMed ID: 21707496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy of gliomas.
    Hamel W; Westphal M
    Acta Neurochir Suppl; 2003; 88():125-35. PubMed ID: 14531570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single vs. combination immunotherapeutic strategies for glioma.
    Chandran M; Candolfi M; Shah D; Mineharu Y; Yadav VN; Koschmann C; Asad AS; Lowenstein PR; Castro MG
    Expert Opin Biol Ther; 2017 May; 17(5):543-554. PubMed ID: 28286975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy for brain tumors: basic developments and clinical implementation.
    Assi H; Candolfi M; Baker G; Mineharu Y; Lowenstein PR; Castro MG
    Neurosci Lett; 2012 Oct; 527(2):71-7. PubMed ID: 22906921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy of malignant glioma: recent advances in experimental and clinical studies.
    Sasaki M; Plate KH
    Ann Oncol; 1998 Nov; 9(11):1155-66. PubMed ID: 9862044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T
    Hum Cell; 2002 Sep; 15(3):151-9. PubMed ID: 12703545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-receptor gene-modified T cells for treatment of glioma.
    Ikeda H; Shiku H
    Adv Exp Med Biol; 2012; 746():202-15. PubMed ID: 22639170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principles of immunotherapy.
    Liebelt BD; Finocchiaro G; Heimberger AB
    Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical trials with retrovirus mediated gene therapy--what have we learned?
    Rainov NG; Ren H
    J Neurooncol; 2003 Dec; 65(3):227-36. PubMed ID: 14682373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.
    Selznick LA; Shamji MF; Fecci P; Gromeier M; Friedman AH; Sampson J
    Neurosurg Rev; 2008 Apr; 31(2):141-55; discussion 155. PubMed ID: 18259789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies.
    Wang JY; Bettegowda C
    J Neurooncol; 2015 Jul; 123(3):373-83. PubMed ID: 25697584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting in gene therapy for gliomas.
    Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
    Arch Neurol; 1999 Apr; 56(4):445-8. PubMed ID: 10199333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.
    Huang TT; Parab S; Burnett R; Diago O; Ostertag D; Hofman FM; Espinoza FL; Martin B; Ibañez CE; Kasahara N; Gruber HE; Pertschuk D; Jolly DJ; Robbins JM
    Hum Gene Ther; 2015 Feb; 26(2):82-93. PubMed ID: 25419577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
    Kroeger KM; Muhammad AK; Baker GJ; Assi H; Wibowo MK; Xiong W; Yagiz K; Candolfi M; Lowenstein PR; Castro MG
    Discov Med; 2010 Oct; 10(53):293-304. PubMed ID: 21034670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in immunotherapeutic research for glioma therapy.
    Miyauchi JT; Tsirka SE
    J Neurol; 2018 Apr; 265(4):741-756. PubMed ID: 29209782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.